Abiopharma

EVNIN LUKE 🔴 sold 83.0K shares of Werewolf Therapeutics, Inc. (HOWL) at $1.08 Transaction Date: Dec 10, 2025 | Filing ID: 000016

New Form 424B5 - Tiziana Life Sciences Ltd Filed: 2025-12-12 AccNo: 0001213900-25-121308 Size: 525 KB

(99% Neutral) Bausch Health Companies Inc. (BHC) Files Form 8-K

(99% Neutral) Bausch & Lomb Corp (BLCO) Files Form 8-K

New Form 424B5 - Aditxt, Inc. Filed: 2025-12-12 AccNo: 0001213900-25-121306 Size: 37 KB

📋 HAROLD SHLEVIN (DIRECTOR) plans to sell 20K shares of GALECTIN THERAPEUTICS INCORPORATED (at $6.21 each, total $123K) Filed: Dec 12, 2025 | ID: 056844

New Form S-8 - Axe Compute Inc. Filed: 2025-12-12 AccNo: 0001171843-25-007924 Size: 194 KB

📋 OCTAVIO ESPINOZA (Officer) plans to sell 2K shares of LIGAND PHARMACEUTICALS INCORPORATED (at $188.31 each, total $340K) Filed: Dec 12, 2025 | ID: 010259

New Form SCHEDULE 13D/A - Immunovant, Inc. Filed: 2025-12-12 AccNo: 0001140361-25-045411 Size: 10 KB

📋 Atlas Venture Opportunity Fund I, L.P. (Director) plans to sell 108 shares of Kymera Therapeutics, Inc. (at $89.68 each, total $10K) Filed: Dec 12, 2025 | ID: 000093